News & Press Releases

GENSTAR CAPITAL ANNOUNCES ACQUISITION OF ONCURE MEDICAL CORP.

OnCure Medical was sold to Genstar Capital in August 2006. The company achieved Revenue and EBITDA growth of 230% and 340% respectively, since MedEquity's investment in 2003. MedEquity's investment yielded a compound annual return in excess of 64%.

William Blair & Company acted as financial advisor to OnCURE Medical Corporation, a portfolio company of Halpern, Denny & Co., Crossbow Ventures Inc. and MedEquity Capital, LLC, in conjunction with its acquisition by Genstar Capital, LLC. Terms of the transaction are not being disclosed.

Headquartered in Newport Beach, California, OnCURE is a provider of radiation therapy services to cancer patients. OnCURE owns, operates and manages treatment centers focused exclusively on providing radiation treatment alternatives ranging from conventional external beam radiation to newer, technologically-advanced options such as Intensity Modulated Radiation Therapy and Image Guided Radiation Therapy. OnCURE currently provides radiation therapy services in 33 treatment centers located in California and Florida. OnCURE was founded in 1998 and is one of the largest radiation oncology providers in the U.S.

Based in San Francisco, Genstar Capital is a private equity investment firm that makes leveraged investments in quality middle-market companies. With more than $900 million of committed capital under management and significant experience investing in businesses, Genstar focuses on selected segments of the life sciences, business services, and industrial technology sectors.